Literature DB >> 15078844

Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?

Irene Wai Yan Ma1, Michelle Hladunewich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15078844      PMCID： PMC385352          DOI： 10.1503/cmaj.1040312

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast.

Authors:  Fernando Boccalandro; Muhammad Amhad; Richard W Smalling; Stefano Sdringola
Journal:  Catheter Cardiovasc Interv       Date:  2003-03       Impact factor: 2.692

2.  The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography.

Authors:  Shai Efrati; Victor Dishy; Michael Averbukh; Alex Blatt; Ricardo Krakover; Joshua Weisgarten; Jason D Morrow; Michael C Stein; Ahuva Golik
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

3.  A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study.

Authors:  Christopher S R Baker; Andrew Wragg; Sanjay Kumar; Rodney De Palma; Laurence R I Baker; Charles J Knight
Journal:  J Am Coll Cardiol       Date:  2003-06-18       Impact factor: 24.094

4.  Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.

Authors:  Briain D MacNeill; Scott A Harding; Hasan Bazari; Kristen K Patton; Pedro Colon-Hernadez; Denise DeJoseph; Ik-Kyung Jang
Journal:  Catheter Cardiovasc Interv       Date:  2003-12       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.